Subarachnoid hemorrhage: management considerations for COVID-19.

COVID-19 Subarachnoid hemorrhage matrix metalloproteinase 9 outcomes renin-angiotensin pathway

Journal

Exploration of neuroprotective therapy
ISSN: 2769-6510
Titre abrégé: Explor Neuroprotective Ther
Pays: United States
ID NLM: 9918282980006676

Informations de publication

Date de publication:
2022
Historique:
entrez: 28 3 2022
pubmed: 29 3 2022
medline: 29 3 2022
Statut: ppublish

Résumé

Subarachnoid hemorrhage (SAH) has deleterious outcomes for patients, and during the hospital stay, patients are susceptible to vasospasm and delayed cerebral ischemia. Coronavirus disease 2019 (COVID-19) has been shown to worsen hypertension through angiotensin-converting enzyme 2 (ACE2) activity, therefore, predisposing to aneurysm rupture. The classic renin-angiotensin pathway activation also predisposes to vasospasm and subsequent delayed cerebral ischemia. Matrix metalloproteinase 9 upregulation can lead to an inflammatory surge, which worsens outcomes for patients. SAH patients with COVID-19 are more susceptible to ventilator-associated pneumonia, reversible cerebral vasoconstriction syndrome, and respiratory distress. Emerging treatments are warranted to target key components of the anti-inflammatory cascade. The aim of this review is to explore how the COVID-19 virus and the intensive care unit (ICU) treatment of severe COVID can contribute to SAH.

Identifiants

pubmed: 35340712
doi: 10.37349/ent.2022.00018
pmc: PMC8951071
mid: NIHMS1784203
doi:

Types de publication

Journal Article

Langues

eng

Pagination

65-73

Subventions

Organisme : NINDS NIH HHS
ID : R25 NS108939
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest The authors declare that they have no conflicts of interest.

Références

Nat Rev Neurol. 2014 Jan;10(1):44-58
pubmed: 24323051
J Autoimmun. 2021 Jul;121:102662
pubmed: 34051613
Ann Intensive Care. 2021 Nov 26;11(1):159
pubmed: 34825976
Arch Virol. 1999;144(7):1361-70
pubmed: 10481742
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211003983
pubmed: 33784877
Interdiscip Neurosurg. 2022 Mar;27:101437
pubmed: 34868884
Compr Physiol. 2012 Oct;2(4):2733-52
pubmed: 23720263
J Neurosurg Anesthesiol. 2022 Jan 1;34(1):e57-e62
pubmed: 33075034
Biomed Res Int. 2018 Oct 9;2018:5423639
pubmed: 30402484
Br J Neurosurg. 1998 Feb;12(1):37-40
pubmed: 11013646
BMJ Case Rep. 2021 Oct 7;14(10):
pubmed: 34620638
Turk Neurosurg. 2019;29(3):434-439
pubmed: 30984987
Stroke. 2000 Apr;31(4):901-6
pubmed: 10753996
Stroke. 1998 Sep;29(9):1995-8
pubmed: 9731629
Front Immunol. 2021 Jun 11;12:649122
pubmed: 34177896
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105011
pubmed: 32807426
N Engl J Med. 2021 Oct 28;385(18):1680-1689
pubmed: 34379914
J Neurosurg. 2017 Feb;126(2):518-526
pubmed: 27058204
Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):5
pubmed: 35035211
Neurocrit Care. 2021 Nov 30;:
pubmed: 34850332
Expert Opin Investig Drugs. 2022 Feb;31(2):173-192
pubmed: 35040388
Crit Care. 2019 Aug 6;23(1):273
pubmed: 31387627
Radiology. 2020 Aug;296(2):E119-E120
pubmed: 32228363
J Neurosurg. 2021 Dec 31;:1-12
pubmed: 34972088
Cureus. 2022 Jan 4;14(1):e20944
pubmed: 35004089
Res Pract Thromb Haemost. 2021 Sep 01;5(6):e12572
pubmed: 34485807
Sci Rep. 2020 Sep 23;10(1):15492
pubmed: 32968087
AJNR Am J Neuroradiol. 2006 Jan;27(1):26-34
pubmed: 16418351
Front Immunol. 2022 Jan 12;12:782335
pubmed: 35095856
Chin Neurosurg J. 2021 Dec 1;7(1):44
pubmed: 34847937
Neurocrit Care. 2021 Jun;34(3):1000-1008
pubmed: 33083966
J Neurointerv Surg. 2021 Nov 15;:
pubmed: 34782400
Egypt J Neurosurg. 2021;36(1):27
pubmed: 34988372
Sci Rep. 2021 Mar 3;11(1):5105
pubmed: 33658581
Chest. 2021 Oct 13;:
pubmed: 34655568
Clin Neurol Neurosurg. 2021 Mar;202:106495
pubmed: 33493886
Crit Care Med. 2015 Nov;43(11):2429-38
pubmed: 26308429
Recent Trends Pharm Sci Res. 2021;3(2):16-30
pubmed: 34984419
J Intensive Care Med. 2018 Jun;33(6):370-374
pubmed: 29747562
J Clin Neurosci. 2022 Mar;97:1-6
pubmed: 34999308
PLoS Med. 2021 May 24;18(5):e1003648
pubmed: 34029337
World Neurosurg. 2021 Oct;154:199
pubmed: 34583492
Neuropathology. 2019 Aug;39(4):259-267
pubmed: 31074912
Angiology. 2021 Dec 10;:33197211053903
pubmed: 34889662
World Neurosurg. 2021 Nov;155:200-201
pubmed: 34724737
Medicine (Baltimore). 2020 Dec 18;99(51):e23862
pubmed: 33371170
Cell Death Discov. 2019 Jun 24;5:106
pubmed: 31263574

Auteurs

Eric J Panther (EJ)

College of Medicine, University of Florida, Gainesville, Florida 32610, USA.

Brandon Lucke-Wold (B)

Department of Neurosurgery, University of Florida, Gainesville, Florida 32610, USA.

Classifications MeSH